2011
DOI: 10.1504/ijbg.2011.041829
|View full text |Cite
|
Sign up to set email alerts
|

Licencing as a commercialisation strategy under different institutional contexts: a comparative empirical analysis of German and Chinese biotechnology firms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…In addition, patents increase the opportunities to generate revenues from inventions. Specifically, patents facilitate the selling and licensing of technologies and, thus, provide additional forms of economic returns than the (traditional) commercialisation of products (Chen et al 2011). Given the increasing relevance of the market for technologies (Moreira et al 2019), we might suspect that M&A-acquiring firms consider patents more valuable than other types of innovation.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, patents increase the opportunities to generate revenues from inventions. Specifically, patents facilitate the selling and licensing of technologies and, thus, provide additional forms of economic returns than the (traditional) commercialisation of products (Chen et al 2011). Given the increasing relevance of the market for technologies (Moreira et al 2019), we might suspect that M&A-acquiring firms consider patents more valuable than other types of innovation.…”
Section: Resultsmentioning
confidence: 99%